Axsome Therapeutics
AXSM
AXSM
174 hedge funds and large institutions have $1.71B invested in Axsome Therapeutics in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 73 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
33% less call options, than puts
Call options by funds: $44.5M | Put options by funds: $66.2M
36% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 73
42% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 36
Holders
174
Holding in Top 10
5
Calls
$44.5M
Puts
$66.2M
Top Buyers
| 1 | +$46.7M | |
| 2 | +$45.4M | |
| 3 | +$22.4M | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$11.8M |
| 5 |
Jane Street
New York
|
+$8.49M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$19.9M | |
| 3 | -$16M | |
| 4 |
Citigroup
New York
|
-$13.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12M |